The directors present the strategic report for the year ended 30 June 2025.

We are pleased to report a revenue growth of over 1.7% this year, with a £217,000 increase in sales across the group. This marks another year of positive momentum as we continue striving to return to the performance levels seen in 2018.

Like many in the industry, our group and others in our industry have felt the impact of the rising cost of living and the ongoing NHS dental crisis. Limited access to NHS dental services—especially for new patients—and the challenges posed by the current NHS dental contract continue to affect operations. However, we are hopeful that initiatives such as the NHS Dental Recovery Plan, which aims to expand urgent care access and reform the contract, will support practices in seeing more patients and promoting better oral hygiene.

Despite these challenges, CTS Dental Holdings has remained strong. We continue to be recognized as a leader in oral hygiene, surgical consumables, and whitening products, supporting dental professionals and practices across the UK.

Business Strategy

Our strategic focus is to strengthen our position as a market leader in oral hygiene, whitening, and infection control by:

1. Offering a Comprehensive Product Range
   Providing a wide selection of oral hygiene, whitening, and infection control products at competitive prices to meet the diverse needs of our customers.

2. Expanding Digital Reach
   Enhancing our marketing and ordering platforms to engage a broader audience and improve customer experience.

3. Empowering Dental Practices
   Delivering retail and product training to our partner practices, enabling them to boost sales and profitability.

4. Supporting Optimal Patient Care
   Equipping practices with an extensive product range to offer tailored oral care solutions for all patient needs.

5. Driving Innovation and Growth
   Identifying new, profitable opportunities within the sector, including sourcing innovative brands and products to fuel continued business growth.

6. Championing Sustainability
   Exploring and promoting biodegradable product options to reduce our environmental impact and support eco-conscious practices.

7. Maintaining and Growing Market Share
   Continuing to strengthen our presence and influence within the dental industry.

8. Expanding Whitening Solutions
   Growing our market share in the whitening segment by offering a complete solution, including the development and promotion of our own brand.

Revenue Growth
Group revenue increased by £217k, reaching £12.8m (2024: £12.6m), driven by strong sales in key product categories:

• Gloves: +48.18%

• Whitening Products: +3.44%

• Orthodontics (Ortho): +16.07%

• Floss & Oral Hygiene: Continued growth

This growth reflects our strategic partnerships with suppliers to offer high-quality gloves at competitive prices, and our tailored ortho kits developed in collaboration with practices. CTS continues to be a one-stop shop for dental professionals, offering the largest range of whitening products in the market.

Product Portfolio Expansion
We’ve strengthened our offering by adding new brands, including the distribution of KIN products, and remain committed to expanding our portfolio to meet evolving customer needs.

Training & Education
Our ongoing investment in training and education for dental practices and groups supports both professional development and improved patient outcomes, reinforcing our leadership in oral hygiene.

• Gross Margin: Increased slightly to 25.71%

• Loss Before Tax: £358k (2024: £832k profit), impacted by a Director’s resolution to waive a related debt of £1.6M

• Sales Growth: +1.7%

• Overheads excluding amortisation and debt waiver: Increased by 3.84%, reflecting strategic investments in recruitment and staff rewards

• Net Profit: Maintained at a healthy 7.3%, after adjusting for the related debt waiver.

Despite rising supplier costs and general inflationary pressures, CTS chose not to pass these increases onto customers, prioritizing long-term relationships and value.

These, together with gross profit and profit before tax remain the financial key performance indicators ("KPls") that the directors have identified to be the most effective method for monitoring the group's performance.

                        2025          2024

                         £         £

Revenue                 12,856,011     12,638,978    

Gross Profit                 3,305,314     3,240,777        

(Loss)/Profit before tax              (357,648)     832,143

CTS Dental Holdings is proud to be the only wholesaler offering seven distinct whitening systems to dental practices at competitive rates. This empowers practices with freedom of choice, rather than limiting them to a single solution. Among these systems is our own-brand whitening kit, which is the first in the market to feature fully biodegradable syringes, tray boxes, and pouches. Each kit sold also contributes to polar bear research, reinforcing our commitment to sustainability and global impact.

We’ve also partnered with a high-quality laboratory to provide a tray service for both our own brand and other whitening systems, enhancing convenience and clinical outcomes for practices.

Our mission continues to be evolve and educate. This year, we aim to:

• Collaborate closely with our team and practices to help them launch concepts that enhance clinical choices and revenue.

• Work with suppliers to deliver unique offerings, including support, education, and marketing tools.

• Help practices maximize every sale, ensuring patients purchase directly from their trusted dental providers.

Our Profit Builder Scheme has already demonstrated success, with participating practices seeing sales increases of over 40%.

We’ve invested in attending conferences, exhibitions, forums, and events, strengthening relationships with practices and dental groups. Our supplier partnerships have positioned us as the preferred distributor for select product ranges, enabling us to offer:

• Exclusive promotions

• Sales tools

• Competitive pricing

We continue to refine our supply chain, ensuring key products and suitable alternatives are available to keep practices operational and well-stocked.

CTS is committed to offering greener product choices, including:

• A sustainable and recyclable electric toothbrush

• Biodegradable surgery items such as wipes

• Ongoing research into eco-friendly glove options

Despite economic pressures, group profitability remains healthy, reflecting our strategic investments and customer-first approach.

Principal risks and uncertainties

The directors consider the principal risks and uncertainties affecting the business are to be an ongoing impact of increased costs and the products being available on the internet.

Market risk:

To maintain our strong market position, CTS Dental Holdings continues to:

• Offer a comprehensive and evolving product range tailored to the needs of dental practices.

• Foster strong relationships with existing partners while actively pursuing new opportunities.

• Lead the market in innovation, often being the first to launch new products and solutions.

We remain the only wholesaler offering the largest range of whitening systems, now including our own eco-conscious brand. This system features biodegradable packaging and supports polar bear research through donations from each kit sold. Our partnership with a high-quality lab also enables us to offer a tray service across all whitening systems, enhancing convenience and clinical outcomes.

We are mindful of supply chain risks and continue to expand our product range with reliable alternatives to mitigate potential disruptions.

One of the key challenges we face is educating practices on the value of retailing oral hygiene products. This not only ensures patients receive the best clinical care but also helps practices retain revenue that might otherwise be lost to online retailers.

To address this, we’ve launched new concepts and initiatives—including our Profit Builder Scheme, which has already shown a 40%+ increase in practice sales. These efforts will continue to evolve in collaboration with our practices.

We are actively collaborating with dental practices to provide tailored marketing packs and support materials aimed at increasing patient awareness and uptake of whitening treatments. These resources are designed to help practices promote whitening services effectively, both in-clinic and through digital channels.

Additionally, we are working with a digital practice TV company to enhance in-practice engagement. This initiative will feature targeted content on waiting room screens to encourage patients to consider whitening treatments while they are in the practice environment.

We remain committed to listening to our customers and making it easy for them to engage with us. Practices can place orders via:

• Web

• Email

• WhatsApp

• Instagram

We also maintain strong visibility through calls, visits, and social media marketing, ensuring we stay connected and responsive to practice needs.

CTS Dental Holdings remains proactive in identifying and mitigating key risks that could impact operations and growth. Below is a summary of our approach to managing legislative, liquidity, and competitive risks:

Legislative and regulatory risk

The group is subject to ongoing legislative and regulatory changes, particularly in relation to the control of medicinal products. To mitigate this risk, we:

• Continuously monitor regulatory developments to ensure compliance.

• Ensure our IT systems are adaptable to accommodate new requirements.

• Provide ongoing training to all staff, ensuring procedures are followed and compliance is maintained across the business.

Liquidity risk

We maintain a strong financial position to meet obligations as they arise. Key measures include:

• Maintaining sufficient cash reserves and using cash at bank to manage working capital.

• Preparing financial forecasts and quarterly management accounts to monitor liquidity and ensure financial stability.

Actions of competitors:

While we actively monitor competitor activity, we remain confident in our market position due to:

• A customer-first approach built on 49 years of trusted relationships.

• A unique product offering, including exclusive brands, innovative whitening systems, and bespoke selling concepts.

• A commitment to high-quality service, education, and marketing support that differentiates us in the marketplace.

The Board remains committed to driving innovation, expanding product choice, and enhancing customer experience. Key areas of focus include:

Expanding Product Choice

We continue to explore and introduce new and own-brand products, ensuring our customers have access to a comprehensive range without the need to shop around. This supports our goal of being a true one-stop shop for dental practices.

Investing in People

We are investing in our team to ensure they are equipped to support practices with the best oral hygiene and whitening solutions. This includes recruitment, training, and development to maintain our high standards of service and expertise.

Enhancing IT Infrastructure

Ongoing investment in our IT systems will provide customers with a safe, seamless, and convenient shopping experience. Internally, upgraded infrastructure will empower our staff to better train, support, and engage with customers, while staying up to date with the latest product innovations.

Training & Education Initiatives

As part of our commitment to continuous learning, we offer:

• Coffee Meetings and “Lunch and Learn” sessions

• Virtual training on new product launches

• Ongoing collaboration with dental professionals to ensure they can offer the latest clinical solutions to their patients

These initiatives not only support professional development but also help practices grow their revenue and improve patient care.

On behalf of the board

The directors present their annual report and financial statements for the year ended 30 June 2025.

The results for the year are set out on page 11.

Ordinary dividends were paid amounting to £760,000 (2024: £860,000). The directors do not recommend payment of a further dividend.

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

The auditor, Sumer Audit, is deemed to be reappointed under section 487(2) of the Companies Act 2006.

The truegroup has chosen in accordance with Companies Act 2006, s. 414C(11) to set out in the group's strategic report information required by Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008, Sch. 7 to be contained in the directors' report. It has done so in respect of financial instruments, principal risks and uncertainties, future development and principal activities.

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the auditor of the company is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the auditor of the company is aware of that information.

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the or of the company for that period. In preparing these financial statements, the directors are required to:

• select suitable accounting policies and then apply them consistently;

• make judgements and accounting estimates that are reasonable and prudent;

• state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;

• prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

We have audited the financial statements of CTS Dental Holdings Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 30 June 2025 which comprise the group statement of comprehensive income, the group statement of financial position, the company statement of financial position, the group statement of changes in equity, the company statement of changes in equity, the group statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

• give a true and fair view of the state of the group's and the parent company's affairs as at 30 June 2025 and of the group's loss for the year then ended;

• have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

• have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the group and parent company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

• the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

• the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.

In the light of the knowledge and understanding of the group and the parent company and their environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

• adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or

• the parent company financial statements are not in agreement with the accounting records and returns; or

• certain disclosures of directors' remuneration specified by law are not made; or

• we have not received all the information and explanations we require for our audit.

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the parent company or to cease operations, or have no realistic alternative but to do so.

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

In identifying and assessing risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, our procedures included the following:

• Obtaining an understanding of the legal and regulatory framework that the group operates in, focusing on those laws and regulations that had a direct effect on the financial statements and operations;

• Obtaining an understanding of the group’s policies and procedures on fraud risks, including knowledge of any actual, suspected or alleged fraud; and

• Discussing among the engagement team how and where fraud might occur in the financial statements and any potential indicators of fraud through our knowledge and understanding of the group and our sector-specific experience.

As a result of these procedures, we considered the opportunities and incentives that may exist within the group for fraud. We are also required to perform specific procedures to respond to the risk of management override. As a result of performing the above, we identified the following areas as those most likely to have an impact on the financial statements: health & safety, employment law and compliance with the UK Companies Act.

In addition to the above, our procedures to respond to risks identified included the following:

• Making enquiries of management about any known or suspected instances of non-compliance with laws and regulations and fraud;

• Challenging assumptions and judgements made by management in their significant accounting estimates; and

• Auditing the risk of management override of controls, including through testing journal entries and other adjustments for appropriateness.

Due to the inherent limitations of an audit, there is an unavoidable risk that some material misstatements in the financial statements may not be detected, even though the audit is properly planned and performed in accordance with the ISAs (UK). For instance, the further removed non-compliance is from the events and transactions reflected in the financial statements, the less likely the auditor is to become aware of it or to recognise the non-compliance.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

The statement of comprehensive income has been prepared on the basis that all operations are continuing operations.

These financial statements have been prepared in accordance with the provisions relating to medium-sized groups.

As permitted by s408 Companies Act 2006, the company has not presented its own income statement and related notes. The company’s loss for the year was £356,793 (2024 - £1,371,924 profit).

These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.

CTS Dental Holdings Limited (“the company”) is a private limited company domiciled and incorporated in England and Wales. The registered office is Three Arch Business Park, Three Arch Road, Redhill, Surrey, RH1 5SS.

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £1.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

The company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements for parent company information presented within the consolidated financial statements:

• Section 7 ‘Statement of Cash Flows’: Presentation of a statement of cash flow and related notes and disclosures;

• Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instrument Issues: The disclosure requirements of paragraphs 11.42, 11.44, 11.45, 11.47, 11.48(a)(iii), 11.48(a)(iv), 11.48(b), 11.48(c), 12.26, 12.27, 12.29(a), 12.29(b), and 12.29A;

The consolidated financial statements incorporate the trading results and reserves of CTS Dental Holdings Limited and all of its subsidiaries who were wholly owned throughout the year.

The financial statements of both CTS Dental Holdings Limited and Alanic Engineering Limited T/A CTS Dental Supplies are made up to 30 June 2025; the other company within the group remained dormant throughout the current and comparative periods so, although CTS Dental Supplies Limited has a 31 August year end, there have been no implications for the consolidated figures.

All intra-group transactions, balances and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred.

At the time of approving the financial statements, the directors have a reasonable expectation that the group has adequate resources to continue in operational existence for the foreseeable future. The directors have considered relevant information, including the group’s principal risks and uncertainties, the annual budget, forecast future cash flows and the impact of subsequent events in making their assessment. Based on these assessments and having regard to the resources available to the entity, the directors have concluded that there is no material uncertainty and that they can continue to adopt the going concern basis in preparing the annual report and financial statements.

Based on these assessments and having regard to the resources available to the group, the directors have concluded that there is no material uncertainty in relation to the appropriateness of continuing to adopt the going concern basis in preparing the annual report and accounts.

Revenue is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Goodwill represents the excess of the cost of acquisition of a business over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 20 years.

Intangible assets purchased during the year relates to a computer software system, which is capitalised on the basis that future economic benefit will flow to the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Property, plant and equipment are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the income statement.

In the parent company financial statements, investments in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses.

A subsidiary is an entity controlled by the group. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

At each reporting period end date, the group reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

If the recoverable amount of an asset is estimated to be less than its carrying amount, the carrying amount of the asset is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Inventories are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of inventories over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks.

The group has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the group's statement of financial position when the group becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

The group enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and loans from related parties.

Debt instruments like loans and other accounts receivable and payable are initially measured at transaction price and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received.

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire, or when it transfers the financial asset and substantially all the risks and rewards of ownership to another entity. Financial liabilities are derecognised when, and only when, the company’s obligations are discharged, cancelled, or they expire.

Equity instruments issued by the group are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the group.

The tax expense represents the sum of the tax currently payable and deferred tax.

The tax currently payable is based on taxable profit for the year.

Deferred taxation is provided in full in respect of all timing differences that have originated but not reversed at the balance sheet date.

The costs of short-term employee benefits are recognised as a liability and an expense.

The company operates a defined contribution scheme for the benefit of its employees. Contributions payable are charged to the profit and loss account in the year they are payable.

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leased asset are consumed.

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

In the application of the group’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

An analysis of the group's revenue is as follows:

The average monthly number of persons (including directors) employed by the group and company during the year was:

Their aggregate remuneration comprised:

The directors' are considered to be the only key management personnel.

The actual charge for the year can be reconciled to the expected (credit)/charge for the year based on the profit or loss and the standard rate of tax as follows:

Details of the company's subsidiaries at 30 June 2025 are as follows:

1) Three Arch Business Park, Three Arch Road, Redhill, Surrey, RH1 5SS

Amounts owed to group undertakings have no terms and are therefore repayable on demand. Whilst the classification as current liabilities reflects the contractual nature of the loans, the subsidiary does not seek repayment of these loans until the company is financially able to do so. This may be more than 12 months from the reporting date, as part of the company's ongoing financial support.

The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the group in an independently administered fund.

Deferred tax assets and liabilities are offset where the group or company has a legally enforceable right to do so. The following is the analysis of the deferred tax balances (after offset) for financial reporting purposes:

Ordinary shares have attached to them full voting, dividend and capital distribution (including on winding up) rights.

At the reporting end date the group had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

Dividends totalling £760,000 (2024 - £860,000) were declared in the year in respect of shares held by the company's directors.

At the year end, the company was owed £16,020 by the directors (2024 - £8,436 owed by the directors).

Group

At the year end £nil (2024 - £1,604,860) was due from CTS Dental Retail Supplies Ltd, a connected company, to the group. The full balance of £1,605,223 was written off during the year.

Company

At the year end £nil (2024 - £1,166,528) was due from CTS Dental Retail Supplies Ltd, a connected company, to the company. The full balance of £1,166,891 was written off during the year.